A novel rare c.-39C>T mutation in the PROS1 5'UTR causing PS deficiency by creating a new upstream translation initiation codon.


Journal

Clinical science (London, England : 1979)
ISSN: 1470-8736
Titre abrégé: Clin Sci (Lond)
Pays: England
ID NLM: 7905731

Informations de publication

Date de publication:
29 05 2020
Historique:
received: 06 04 2020
revised: 13 05 2020
accepted: 19 05 2020
pubmed: 20 5 2020
medline: 8 10 2020
entrez: 20 5 2020
Statut: ppublish

Résumé

Autosomal dominant inherited Protein S deficiency (PSD) (MIM 612336) is a rare disorder caused by rare mutations, mainly located in the coding sequence of the structural PROS1 gene, and associated with an increased risk of venous thromboembolism. To identify the molecular defect underlying PSD observed in an extended French pedigree with seven PSD affected members in whom no candidate deleterious PROS1 mutation was detected by Sanger sequencing of PROS1 exons and their flanking intronic regions or via an multiplex ligation-dependent probe amplification (MLPA) approach, a whole genome sequencing strategy was adopted. This led to the identification of a never reported C to T substitution at c.-39 from the natural ATG codon of the PROS1 gene that completely segregates with PSD in the whole family. This substitution ACG→ATG creates a new start codon upstream of the main ATG. We experimentally demonstrated in HeLa cells that the variant generates a novel overlapping upstream open reading frame (uORF) and inhibits the translation of the wild-type PS. This work describes the first example of 5'UTR PROS1 mutation causing PSD through the creation of an uORF, a mutation that is not predicted to be deleterious by standard annotation softwares, and emphasizes the need for better exploration of such type of non-coding variations in clinical genomics.

Identifiants

pubmed: 32426810
pii: 224729
doi: 10.1042/CS20200403
doi:

Substances chimiques

5' Untranslated Regions 0
Codon, Initiator 0
PROS1 protein, human 0
Protein S 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1181-1190

Informations de copyright

© 2020 The Author(s).

Auteurs

Sylvie Labrouche-Colomer (S)

CHU de Bordeaux, Laboratoire d'Hématologie, Pessac, France.
INSERM UMR 1034, Biology of Cardiovascular Disease, University of Bordeaux, Pessac, France.

Omar Soukarieh (O)

INSERM UMR 1219, Bordeaux Population Health Research Center, University of Bordeaux, Bordeaux, France.

Carole Proust (C)

INSERM UMR 1219, Bordeaux Population Health Research Center, University of Bordeaux, Bordeaux, France.

Christine Mouton (C)

CHU de Bordeaux, Laboratoire d'Hématologie, Pessac, France.

Yoann Huguenin (Y)

CHU de Bordeaux, Service De Pédiatrie Médicale, Bordeaux, France.

Maguelonne Roux (M)

Human Evolutionary Genetics Unit, Institut Pasteur, UMR2000, CNRS, Paris 75015, France.

Céline Besse (C)

Université Paris-Saclay, CEA, Centre National de Recherche en Génomique Humaine, Evry 91057, France.

Anne Boland (A)

Université Paris-Saclay, CEA, Centre National de Recherche en Génomique Humaine, Evry 91057, France.

Robert Olaso (R)

Université Paris-Saclay, CEA, Centre National de Recherche en Génomique Humaine, Evry 91057, France.

Joël Constans (J)

CHU de Bordeaux, Laboratoire d'Hématologie, Pessac, France.

Jean-François Deleuze (JF)

Université Paris-Saclay, CEA, Centre National de Recherche en Génomique Humaine, Evry 91057, France.
Centre d'Etude du Polymorphisme Humain, Fondation Jean Dausset, Paris, France.

Pierre-Emmanuel Morange (PE)

C2VN INSERM UMR 1263, INRA, Aix-Marseille University, Marseille, France.

Béatrice Jaspard-Vinassa (B)

INSERM UMR 1034, Biology of Cardiovascular Disease, University of Bordeaux, Pessac, France.

David-Alexandre Trégouët (DA)

INSERM UMR 1219, Bordeaux Population Health Research Center, University of Bordeaux, Bordeaux, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH